CXCL13 as a Biomarker of Complex Common Variable Immunodeficiency
CXCL13 can categorise heterogeneous patients with CVID and be used as a biomarker of complex disease.
Authors
- Stephen Jolles (ORCID: https://orcid.org/0000-0002-7394-6804)
- Mohammad A. A. Ibrahim (ORCID: https://orcid.org/0000-0002-0116-597X)
- Hélène Martini (ORCID: https://orcid.org/0000-0001-8789-4585)
- Padmalal Gurugama
- David J. Fear (ORCID: https://orcid.org/0000-0003-0239-8385)
- Ioasaf Karafotias (ORCID: https://orcid.org/0000-0003-2513-215X)
- Mark Peakman (ORCID: https://orcid.org/0000-0003-3328-3513)
- Terrence Hunter
- Mary Guckian
- Charlotte Lee
- Rachael Steven
Institutions
- King's College London (GB)
- University Hospital of Wales (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Kings Health Partners (GB)
- King's College Hospital (GB)
Publication Details
- Journal
- Journal of Clinical Immunology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1007/s10875-025-01963-2
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King's College London